S&P TSX Capped Composite...

US Dollar vs CAD

Level up your trading with our powerful tools and real-time insights all in one place.

Get Started

WVE Wave Life Sciences Ltd

13.67

-1.33 (-8.87%)

After Hours

Last Updated: 15:30:00

Delayed by 15 minutes

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

The sales reported in this Form 144 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2023.

Date of Notice

09/25/2024

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

11/21/2023

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

Kyle Moran

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Wave Life Sciences Charts.

Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Wave Life Sciences Charts.

Wave Life Sciences Ltd News

Form 144 - Report of proposed sale of securities
Friday 15 November 2024 (1 hour ago) • Edgar (US Regulatory)

Wave Life Sciences to Present at Jefferies London Healthcare Conference
Friday 15 November 2024 (9 hours ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 13 November 2024 (2 days ago) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Tuesday 12 November 2024 (3 days ago) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 12 November 2024 (3 days ago) • Edgar (US Regulatory)

Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers
Tuesday 12 November 2024 (3 days ago) • Edgar (US Regulatory)

Wave Life Sciences Reports Third Quarter 2024 Financial Results and Provides Business Update
Tuesday 12 November 2024 (3 days ago) • GlobeNewswire Inc.

Form 144 - Report of proposed sale of securities
Friday 8 November 2024 (1 week ago) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Friday 8 November 2024 (1 week ago) • Edgar (US Regulatory)

Wave Life Sciences Third Quarter 2024 Financial Results Scheduled for November 12, 2024
Monday 4 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 30 October 2024 (2 weeks ago) • Edgar (US Regulatory)

Wave Life Sciences Highlights Growing Pipeline at Research Day, including INHBE siRNA Program for Obesity and New RNA Editing Programs
Wednesday 30 October 2024 (2 weeks ago) • GlobeNewswire Inc.

More Wave Life Sciences Ltd News Articles

Decentral Life (PK)

Elite Pharmaceuticals (QB)

Kraig Biocraft Laborator... (QB)

Movement Industries (PK)

Super Micro Computer

CyberFuels (PK)

FuelCell Energy

Accredited Solutions (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions